As an IL-6 family cytokine with the neurodevelopmental function that participates in the regulation of the tumor immune microenvironment, CLCF1 has also been found to be a promising prognostic marker and target associated with PTEN mutation in glioma in a recent study (21), but its specific role remains to be further explored. This evidence concerns the gene CLCF1 and central nervous system cancer.